在骨关节炎中安慰剂效应:对治疗和药物开发的影响
Tuhina Neogi1, Luana Colloca2,3
1Section of Rheumatology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Nature reviews. Rheumatology
|September 11, 2023
概括
骨关节炎 (OA) 管理侧重于缓解症状,因为缺乏疾病修饰治疗方法. 了解安慰剂反应是改善临床试验和潜在增强OA症状管理的关键.
科学领域:
- 类风湿病学 类风湿病学
- 临床药理学 临床药理学
- 生物统计学 生物统计学
背景情况:
- 骨关节炎 (OA) 是一种普遍的全球性疾病,影响5亿人,其特点是疼痛和功能下降.
- 目前的OA治疗提供了适度的疗效,主要是治疗症状,缺乏疾病修饰剂.
- 针对OA的药物开发面临诸多挑战,包括疾病进展,针对已确定的疾病以及严格的监管批准要求.
研究的目的:
- 探索安慰剂反应对骨关节炎临床试验的影响.
- 了解OA中安慰剂反应者的表现和鉴定.
- 为了利用对安慰剂效应的洞察力,改进OA临床试验设计和患者管理.
主要方法:
- 审查有关骨关节炎病理生理学和治疗的现有文献.
- 在临床试验环境中对安慰剂反应现象的分析.
- 在OA研究中探索减轻安慰剂效应的策略.
主要成果:
- 在OA试验中的安慰剂反应显著复杂化了有效治疗方法的识别.
- 了解安慰剂反应的个体变异性对于试验解释至关重要.
- 虽然安慰剂效应通常是短暂的,但它是OA症状报告的重要因素.
结论:
- 目前没有有效的治疗方法来阻止骨关节炎的进展.
- 改善对安慰剂反应的理解和缓解对于推进OA药物开发至关重要.
- 利用安慰剂效应可能为在临床实践中增强OA症状管理提供新的策略.
相关概念视频
The Placebo Effect
6.2K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.2K
Analgesia and Pain Management
652
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
652
Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152
Principles of Drug Action
6.1K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.1K
Blind Procedures
10.7K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.7K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
144
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
144


